KR950703522A - 벤젠설폰아미드유도체 및 그 용도 - Google Patents

벤젠설폰아미드유도체 및 그 용도 Download PDF

Info

Publication number
KR950703522A
KR950703522A KR1019950701243A KR19950701243A KR950703522A KR 950703522 A KR950703522 A KR 950703522A KR 1019950701243 A KR1019950701243 A KR 1019950701243A KR 19950701243 A KR19950701243 A KR 19950701243A KR 950703522 A KR950703522 A KR 950703522A
Authority
KR
South Korea
Prior art keywords
alkyl group
group
phenyl
hydrogen atom
butyric acid
Prior art date
Application number
KR1019950701243A
Other languages
English (en)
Korean (ko)
Inventor
야스오 이토
히데오 카토
신오 야스다
노부오 오가와
순이치로 사꾸라이
토미오 스즈끼
Original Assignee
이토 마사노리
호쿠리쿠세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이토 마사노리, 호쿠리쿠세이야꾸 가부시끼가이샤 filed Critical 이토 마사노리
Publication of KR950703522A publication Critical patent/KR950703522A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019950701243A 1992-10-01 1993-09-29 벤젠설폰아미드유도체 및 그 용도 KR950703522A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP93-284938 1992-10-01
JP28493892 1992-10-01
JP93-165041 1993-06-11
JP16504193 1993-06-11
PCT/JP1993/001382 WO1994007848A1 (en) 1992-10-01 1993-09-29 Benzenesulfonamide derivative and use thereof

Publications (1)

Publication Number Publication Date
KR950703522A true KR950703522A (ko) 1995-09-20

Family

ID=26489927

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701243A KR950703522A (ko) 1992-10-01 1993-09-29 벤젠설폰아미드유도체 및 그 용도

Country Status (8)

Country Link
US (1) US5597848A (US20100012521A1-20100121-C00001.png)
EP (1) EP0663392A4 (US20100012521A1-20100121-C00001.png)
JP (1) JPH0753505A (US20100012521A1-20100121-C00001.png)
KR (1) KR950703522A (US20100012521A1-20100121-C00001.png)
AU (1) AU4833993A (US20100012521A1-20100121-C00001.png)
CA (1) CA2144780A1 (US20100012521A1-20100121-C00001.png)
TW (1) TW245638B (US20100012521A1-20100121-C00001.png)
WO (1) WO1994007848A1 (US20100012521A1-20100121-C00001.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd （２−チエニル）アルカン酸誘導体
JPH10195038A (ja) * 1996-11-13 1998-07-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びそれを含有する医薬
DE69805973T2 (de) * 1997-01-31 2002-12-19 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
FR2827280B1 (fr) * 2001-07-13 2003-10-31 Servier Lab Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003244913A1 (en) * 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
JP2007508242A (ja) * 2003-08-07 2007-04-05 ビー．エム．アール．エイ． コーポレイション ベスローテン フェンノートシャップ トロンボキサンａ２受容体アンタゴニストとシクロオキシゲネーゼ−１の阻害剤との組み合わせを伴う組成物および方法
ITMI20061297A1 (it) * 2006-07-04 2008-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della'acido (r)-(-)-3-(carbamoilmetil)-5-metilesanoico e del pregabalin e intermedi di sintesi
US8551489B2 (en) 2008-01-03 2013-10-08 Musc Foundation For Research Development Methods for the treatment of cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3821540A1 (de) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel

Also Published As

Publication number Publication date
US5597848A (en) 1997-01-28
WO1994007848A1 (en) 1994-04-14
AU4833993A (en) 1994-04-26
JPH0753505A (ja) 1995-02-28
EP0663392A4 (en) 1995-09-13
TW245638B (US20100012521A1-20100121-C00001.png) 1995-04-21
CA2144780A1 (en) 1994-04-14
EP0663392A1 (en) 1995-07-19

Similar Documents

Publication Publication Date Title
KR900018073A (ko) 피페라진 화합물
ATE255579T1 (de) Pyrrolidin-derivate die eine phospholipase-a2- hemmende wirkung haben
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
KR950017949A (ko) 벤조티오펜 화합물과 수용성 사이클로덱스트린의 수용성 내포착물, 및 그의 약학제제 및 제조 방법
EP0092158A3 (en) Thiazolidine compound and fungicidal composition containing it
KR950016731A (ko) 지루 및 좌창의 억제 방법
IS7482A (is) Fjölhringa efnasambönd sem sterk alfa2-adrenóviðtakamótlyf
KR950703522A (ko) 벤젠설폰아미드유도체 및 그 용도
KR950016722A (ko) Ldl 산화 및 죽상동맥경화증의 억제 방법
KR950703554A (ko) 피페라진 유도체 및 그의 염(piperazine derivatives and salts thereof)
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
KR930703292A (ko) 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
KR950703527A (ko) 프로스타글란딘 유도체
KR960031422A (ko) 신규한 레티노이드
KR920009855A (ko) 비닐화합물의 중합방지제 및 중합 방지법
KR950702530A (ko) 프로스타글란딘 유도체
KR950701329A (ko) 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof)
KR960702832A (ko) 신규한 화합물 및 그 의약으로서의 용도
MX9206930A (es) Nuevos compuestos
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
WO2002026708A1 (fr) Composes conenant de l'azote et inhibiteurs de ccr3 contenant ces composes en tant que principe actif
KR890008121A (ko) 로다닌 유도체 및 약제학적 조성물
ATE172959T1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
KR910000702A (ko) 퀴놀론 카르복실산 유도체

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid